Logo image
Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery
Journal article   Open access

Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery

Jan Horrow, Daniel Van Riper, Michael Strong, Isadore Brodsky, Jonathan Parmet and Jay C Horrow
Circulation (New York, N.Y.), v 84(5), pp 2063-2070
Nov 1991
PMID: 1934382
url
https://doi.org/10.1161/01.cir.84.5.2063View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

BACKGROUNDDesmopressin-induced release of tissue plasminogen activator from endothelial cells may explain the absence of its hemostatic effect in patients undergoing cardiac surgery. Prior administration of the antifibrinolytic drug tranexamic acid might unmask such an effect, and combination therapy might thereby improve postoperative hemostasis. METHODS AND RESULTSA double-blinded design randomly allocated 163 adult patients undergoing coronary revascularization, valve replacement, both procedures, or repair of atrial septal defect to four treatment groupsplacebo, tranexamic acid given as 10 mg/kg over 30 minutes followed by 1 mg. kg. hr for 12 hours initiated before skin incision, desmopressin given as 0.3 μg/kg over 20 minutes after protamine infusion, and both drugs. One surgeon performed all operations. Blood loss consisted of mediastinal tube drainage over 12 hours. Follow-up visits sought evidence of myocardial infarction and stroke. Desmopressin decreased neither the 12-hour blood loss nor the amount of homologous red cells transfused. Tranexamic acid alone significantly reduced 12-hour blood loss, by 30%1 (mean, 318 versus 453 ml; CONCLUSIONSDesmopressin exerts no hemostatic effect, with or without prior administration of antifibrinolytic drug. Prophylactic tranexamic acid alone appears economical and safe in decreasing blood loss and transfusion requirement after cardiac surgery.

Metrics

14 Record Views
155 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Cardiac & Cardiovascular Systems
Peripheral Vascular Disease
Logo image